Anthropic Said to Select Morgan Stanley and Goldman Sachs to Lead 2026 IPO

Published:

Key Takeaways

  • Anthropic is targeting an IPO as early as October 2026; no S-1 has been filed yet — this remains partially verified reporting, not a confirmed mandate.
  • Morgan Stanley and Goldman Sachs are the frontrunner lead underwriters per Polymarket prediction markets and internal planning documents.
  • The strategic implication is cycle validation: Anthropic choosing to go public signals durable institutional appetite for AI equity issuance into late 2026.
  • Primary tradeable angle is relative bank positioning — MS and GS gain ECM franchise and fee-pipeline optionality; JPM and BAC are relative underperformers if excluded.
  • Broader AI equity theme (NASDAQ 100, AI infrastructure names) gets a soft sentiment tailwind as a major frontier-AI lab moves toward public markets.
The NASDAQ 100 Index (US100) opened at 30,576.25 and closed slightly higher at 30,576.35, indicating no change in percentage over the last 24 hours at 0.0%. The index reached a high of 30,759.85 and a low of 30,450.55 during this period, with a total of 25 candles recorded. For leveraged trading, a long position was entered at 30,576.35 with tiers set at 100, 500, and 2000. This chart reflects a stable market environment with no significant leaders or laggards noted in the indices.
NASDAQ 100 Index shows minimal movement with a 24-hour change of 0.0%.

According to reporting corroborated by prediction-market pricing on Polymarket and internal planning documents, Anthropic PBC — the AI safety company behind the Claude family of large language models

Event Analysis

According to reporting corroborated by prediction-market pricing on Polymarket and internal planning documents, Anthropic PBC — the AI safety company behind the Claude family of large language models — is targeting an IPO as early as October 2026, with Goldman Sachs and Morgan Stanley emerging as the frontrunner lead underwriters. As noted in the research, Anthropic has not yet filed an S-1 or any registration statement with the SEC, and no formal mandate has been publicly confirmed. The story is best characterized as partially verified: credible bank discussions are underway, but a locked-in dual-lead mandate remains unconfirmed.

What makes this significant is the signal it sends about the broader AI & Crypto IPO Launch Wave. Anthropic is arguably the most strategically important AI lab yet to go public — a frontier model company with enterprise deployments across financial services, government, and life sciences. A confirmed IPO path institutionalizes the AI trade in a way that venture rounds cannot, moving AI from a private-market story to a publicly priced, index-eligible asset class. This is a qualitative shift, not just another unicorn listing.

For the investment banks involved, the stakes are high. Being joint lead bookrunner on what could be one of the largest tech IPOs of the decade delivers direct fee revenue and critical league-table credit in global ECM/Tech — which compounds into future mandates. Polymarket currently prices Morgan Stanley as the leading outcome (~40–50% implied probability) with Goldman Sachs close behind, per the research report. JPMorgan and Bank of America trail. This is a meaningful franchise differentiator within the IPO Wave & Capital Markets Revival cycle.

The broader implication is one of cycle validation. Anthropic has little urgency to go public — it is heavily funded by hyperscalers and strategics. The decision to begin structuring an IPO reflects confidence that AI equity demand will remain durable into late 2026. That judgment, from one of the best-informed actors in the space, carries weight for how investors price the entire AI infrastructure capital reallocation theme.

What This Means for Traders

The most direct tradeable angle is relative positioning among bulge-bracket banks. If the MS + GS mandate is confirmed, both names receive an incremental sentiment boost tied to ECM franchise strength and a visible future earnings catalyst. Morgan Stanley (MS) and Goldman Sachs (GS) CFDs are tradeable on CoinUnited, and the catalyst path here is milestone-driven: mandate confirmation → confidential filing → public S-1 → roadshow → pricing. Each step is a re-rating opportunity. JPMorgan Chase and peers may face modest relative underperformance if excluded from the lead role.

For broader index exposure, a credible Anthropic IPO path is a soft risk-on signal for the NASDAQ 100 and S&P 500. It validates AI as a durable public-markets theme and supports elevated multiples for AI-infrastructure names — particularly semiconductor and cloud plays covered in the AI monetization and chip demand theme. The effect is sentiment-driven rather than fundamental at this stage, so magnitude is modest and confirmation-dependent.

Traders interested in the pre-IPO angle specifically can explore Anthropic pre-IPO trading and OpenAI pre-IPO trading — both are accessible on CoinUnited's platform. Given this news broke outside standard NYSE hours, CoinUnited's 24/7 stock CFD trading means positioning in MS, GS, or index CFDs doesn't require waiting for the next session open.

Start Trading on CoinUnited.io

Create Your Free Account → — Trade crypto, stocks, forex, indices, and commodities with up to 2000x leverage and zero fees.

Frequently Asked Questions

Yes — CoinUnited offers Anthropic pre-IPO stock trading with up to 100x leverage. See the complete guide for details on how pre-IPO CFDs work.

Disclaimer: This brief is for educational purposes only and is not investment advice.